Bruker Corporation (BRKR)

NMS – Real Time Price. Currency in USD

44.73

+1.46 (3.37%)

At close: May 12, 2026, 4:00 PM EDT

44.48

-0.25 (-0.55%)

After-hours: May 12, 2026, 7:03 PM EDT

07.05.2026

BRKR Stock Up Post Q1 Earnings & Revenue Beat, Margins Down

Bruker beats Q1 earnings and revenue estimates as Europe growth and strong BSI bookings offset margin pressure and softer organic sales.

07.05.2026

Bruker Corporation (BRKR) Q1 2026 Earnings Call Transcript

06.05.2026

Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates

Bruker (BRKR) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.47 per share a year ago.

06.05.2026

Bruker Reports First Quarter 2026 Financial Results

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three months ended March 31, 2026. Frank H. Laukien, Bruker's President and CEO, commented: “While US academic demand, tariff and currency headwinds still pressured our first quarter results, our Q1 financial performance came in ahead of expectations. We are encouraged that our first quarter BSI segment bookings grew organically at a high single digit percentage, and our BSI book-to-bi.

29.04.2026

Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

24.04.2026

Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2026 financial results before market opening on Wednesday, May 6, 2026. The Company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q1 2026 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presenta.

17.04.2026

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

SAN DIEGO--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced new updates from Bruker Spatial Biology to be showcased at the 2026 American Association for Cancer Research (AACR) Annual Meeting. At AACR, Bruker Spatial Biology will highlight how its high-fidelity spatial platforms—designed to work together—deliver deeper insights into oncology biology and accelerate translational research. At AACR 2026, Bruker Spatial Biology will launch new cross‑platform workflows linking GeoMx.

Videos

No Data

There is no data to display

Press releases

06.05.2026

Bruker Reports First Quarter 2026 Financial Results

17.04.2026

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

17.04.2026

Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management

MUNICH--(BUSINESS WIRE)---- $BRKR #BRKR--At ESCMID Global 2026, Bruker announces important portfolio enhancements across microbial identification, outbreak analysis, and reflex next‑generation sequencing (NGS) typing. These latest developments underscore Bruker's continued commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges. MALDI Biotyper® Workflow and Identification Enhancements To further streamline routine MALDI‑TOF w.

17.04.2026

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

MUNICH--(BUSINESS WIRE)---- $BRKR #BRKR--At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division (Bruker Corporation, Nasdaq: BRKR) announces the European launch of MyGenius PRO®, a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology. Designed for infectious disease diagnostics, the new S2A system enables higher throughput, continuous loading of samples, consumables, and reagents, and supports random-access operati.

Bruker Corporation (BRKR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bruker Corporation (BRKR)

BRKR Stock Up Post Q1 Earnings & Revenue Beat, Margins Down

Bruker Corporation (BRKR) Q1 2026 Earnings Call Transcript

Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates

Bruker Reports First Quarter 2026 Financial Results

Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for

Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

Videos

No Data

Press releases

Bruker Reports First Quarter 2026 Financial Results

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

BRKR Stock Up Post Q1 Earnings & Revenue Beat, Margins Down

Bruker Corporation (BRKR) Q1 2026 Earnings Call Transcript

Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates

Bruker Reports First Quarter 2026 Financial Results

Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for

Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

Videos

No Data

Press releases

Bruker Reports First Quarter 2026 Financial Results

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

Search stocks

Bruker Corporation (BRKR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bruker Corporation (BRKR)

BRKR Stock Up Post Q1 Earnings & Revenue Beat, Margins Down

Bruker Corporation (BRKR) Q1 2026 Earnings Call Transcript

Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates

Bruker Reports First Quarter 2026 Financial Results

Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for

Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

Videos

No Data

Press releases

Bruker Reports First Quarter 2026 Financial Results

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

BRKR Stock Up Post Q1 Earnings & Revenue Beat, Margins Down

Bruker Corporation (BRKR) Q1 2026 Earnings Call Transcript

Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates

Bruker Reports First Quarter 2026 Financial Results

Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for

Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

Videos

No Data

Press releases

Bruker Reports First Quarter 2026 Financial Results

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026